Jing‐Ru Weng

3.6k total citations
107 papers, 3.0k citations indexed

About

Jing‐Ru Weng is a scholar working on Molecular Biology, Plant Science and Organic Chemistry. According to data from OpenAlex, Jing‐Ru Weng has authored 107 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 19 papers in Plant Science and 18 papers in Organic Chemistry. Recurrent topics in Jing‐Ru Weng's work include Natural product bioactivities and synthesis (15 papers), Genomics, phytochemicals, and oxidative stress (13 papers) and Natural Compound Pharmacology Studies (11 papers). Jing‐Ru Weng is often cited by papers focused on Natural product bioactivities and synthesis (15 papers), Genomics, phytochemicals, and oxidative stress (13 papers) and Natural Compound Pharmacology Studies (11 papers). Jing‐Ru Weng collaborates with scholars based in Taiwan, United States and Egypt. Jing‐Ru Weng's co-authors include Ching‐Shih Chen, Chun‐Nan Lin, Chang-Fang Chiu, Jih-Pyang Wang, Samuel K. Kulp, Li-Yuan Bai, Lo‐Ti Tsao, Chen-Hsun Tsai, Chang‐Shi Chen and Hsiang‐Yu Lin and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Journal of Agricultural and Food Chemistry.

In The Last Decade

Jing‐Ru Weng

100 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing‐Ru Weng Taiwan 30 1.8k 677 422 372 297 107 3.0k
Ruby John Anto India 34 1.9k 1.1× 633 0.9× 485 1.1× 346 0.9× 436 1.5× 80 3.8k
Vanicha Vichai Thailand 13 1.6k 0.9× 696 1.0× 331 0.8× 447 1.2× 289 1.0× 30 3.4k
Ján Mojžíš Slovakia 32 1.4k 0.8× 762 1.1× 436 1.0× 290 0.8× 221 0.7× 139 3.1k
Petr Džubák Czechia 28 2.1k 1.2× 960 1.4× 285 0.7× 223 0.6× 205 0.7× 157 3.5k
Daniel D. Lantvit United States 31 1.4k 0.8× 315 0.5× 364 0.9× 309 0.8× 275 0.9× 88 2.8k
Santosh Kumar Guru India 34 1.3k 0.7× 849 1.3× 235 0.6× 411 1.1× 197 0.7× 120 2.9k
Ching‐Chuan Kuo Taiwan 37 1.7k 1.0× 1.1k 1.6× 335 0.8× 268 0.7× 330 1.1× 111 3.5k
Pei‐Wen Hsieh Taiwan 32 1.3k 0.7× 493 0.7× 463 1.1× 368 1.0× 209 0.7× 111 2.8k
Rajesh N. Gacche India 29 987 0.6× 867 1.3× 316 0.7× 305 0.8× 285 1.0× 105 2.7k
Sheng-Chu Kuo Taiwan 34 1.6k 0.9× 1.5k 2.2× 208 0.5× 348 0.9× 257 0.9× 101 3.3k

Countries citing papers authored by Jing‐Ru Weng

Since Specialization
Citations

This map shows the geographic impact of Jing‐Ru Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing‐Ru Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing‐Ru Weng more than expected).

Fields of papers citing papers by Jing‐Ru Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing‐Ru Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing‐Ru Weng. The network helps show where Jing‐Ru Weng may publish in the future.

Co-authorship network of co-authors of Jing‐Ru Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Jing‐Ru Weng. A scholar is included among the top collaborators of Jing‐Ru Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing‐Ru Weng. Jing‐Ru Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Tran M, Chia‐Ching Liaw, Yu‐Chi Lin, et al.. (2025). Sarcophytonin H: a novel endoperoxide-containing dihydrofuranocembranoid from an octocoral Sarcophyton species. RSC Advances. 15(12). 9454–9460.
3.
Bai, Li-Yuan, et al.. (2025). A synthetic molecule targeting STAT3 against human oral squamous cell carcinoma cells. International Journal of Medical Sciences. 22(5). 1081–1091. 2 indexed citations
4.
Chen, Jih‐Jung, Ming‐Jen Cheng, Min Tseng, Ming‐Der Wu, & Jing‐Ru Weng. (2023). Natural products from the culture broth of an actinobacteria Streptomyces sp. M5205 and evaluation of their antifungal activity. Phytochemistry Letters. 59. 59–63.
5.
Cheng, Ming‐Jen, et al.. (2023). Secondary metabolites from the leaves of Meliosma rhoifolia and evaluation of their cytotoxic activity. Journal of Molecular Structure. 1288. 135346–135346. 1 indexed citations
6.
Chen, Nan‐Fu, et al.. (2022). Discovering manzamine-related alkaloids from sponge Neopetrosia proxima. Tetrahedron Letters. 95. 153748–153748. 1 indexed citations
8.
Chang, Chih‐Shiang, et al.. (2021). Synthetic Tryptanthrin Derivatives Induce Cell Cycle Arrest and Apoptosis via Akt and MAPKs in Human Hepatocellular Carcinoma Cells. Biomedicines. 9(11). 1527–1527. 15 indexed citations
9.
Huang, Chiung‐Yao, et al.. (2020). New Hydroquinone Monoterpenoid and Cembranoid-Related Metabolites from the Soft Coral Sarcophyton tenuispiculatum. Marine Drugs. 19(1). 8–8. 17 indexed citations
10.
Chen, Liang‐Chieh, Changyi Liu, Jing‐Ru Weng, et al.. (2018). Design of Diarylheptanoid Derivatives as Dual Inhibitors Against Class IIa Histone Deacetylase and β-amyloid Aggregation. Frontiers in Pharmacology. 9. 708–708. 9 indexed citations
11.
Bai, Li-Yuan, Chang-Fang Chiu, Shih-Jiuan Chiu, Po‐Chen Chu, & Jing‐Ru Weng. (2017). FTY720 Induces Autophagy-Associated Apoptosis in Human Oral Squamous Carcinoma Cells, in Part, through a Reactive Oxygen Species/Mcl-1-Dependent Mechanism. Scientific Reports. 7(1). 5600–5600. 37 indexed citations
12.
Bai, Li-Yuan, Jing‐Ru Weng, Chang-Fang Chiu, et al.. (2013). OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis. Biochemical Pharmacology. 86(10). 1430–1440. 25 indexed citations
13.
Weng, Jing‐Ru, Hany A. Omar, Samuel K. Kulp, & Ching‐Shih Chen. (2010). Pharmacological Exploitation of Indole-3-Carbinol to Develop Potent Antitumor Agents. Mini-Reviews in Medicinal Chemistry. 10(5). 398–404. 23 indexed citations
15.
Bai, Li-Yuan, et al.. (2009). OSU-03012 sensitizes TIB-196 myeloma cells to imatinib mesylate via AMP-activated protein kinase and STAT3 pathways. Leukemia Research. 34(6). 816–820. 9 indexed citations
16.
Chiu, Chang-Fang, et al.. (2007). A Novel Single Nucleotide Polymorphism in XRCC4 Gene is Associated with Gastric Cancer Susceptibility in Taiwan. Annals of Surgical Oncology. 15(2). 514–518. 61 indexed citations
17.
Lin, Hsiang‐Yu, Chang‐Shi Chen, Jing‐Ru Weng, & Ching‐Shih Chen. (2006). Targeting histone deacetylase in cancer therapy. Medicinal Research Reviews. 26(4). 397–413. 213 indexed citations
18.
Lin, Meng‐Wei, Lo‐Ti Tsao, Li‐Jiau Huang, et al.. (2005). Inhibition of lipopolysaccharide-stimulated NO production by crotafuran B in RAW 264.7 macrophages involves the blockade of NF-κB activation through the increase in IκBα synthesis. Toxicology and Applied Pharmacology. 210(1-2). 108–115. 12 indexed citations
19.
Weng, Jing‐Ru, Huey‐Jen Su, Ming‐Hong Yen, Shen‐Jeu Won, & Chun‐Nan Lin. (2003). The Cytotoxic Constitunets of Euphorbia Makinoi. Zhōnghuá yàoxué zázhì. 55(4). 267–272. 1 indexed citations
20.
Weng, Jing‐Ru, Chun‐Nan Lin, Lo‐Ti Tsao, & Jih‐Pyang Wang. (2003). Novel and Anti‐Inflammatory Constituents of Garcinia subelliptica. Chemistry - A European Journal. 9(9). 1958–1963. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026